Regan, C L <br/><br/>
Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies.  [electronic resource] 

 -  British journal of obstetrics and gynaecology  Jul 1998 
 - 732-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0306-5456 
<br/><br/><label>Standard No.: </label>10.1111/j.1471-0528.1998.tb10203.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>6-Ketoprostaglandin F1 alpha--analogs & derivatives<br/>Adult<br/>Aspirin--administration & dosage<br/>Cyclooxygenase Inhibitors--administration & dosage<br/>Delayed-Action Preparations<br/>Double-Blind Method<br/>Eicosanoids--urine<br/>Female<br/>Fetal Blood--chemistry<br/>Humans<br/>Pre-Eclampsia--drug therapy<br/>Pregnancy<br/>Thromboxane B2--metabolism